EPA:ALGBE - Euronext Paris - Matif - FR0011052257 - Common Stock - Currency: EUR
EPA:ALGBE (3/7/2025, 7:00:00 PM)
1.248
0 (-0.16%)
The current stock price of ALGBE.PA is 1.248 EUR. In the past month the price increased by 3.14%. In the past year, price decreased by -34.59%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
2OY.DE | DOW INC | 21.63 | 24.12B | ||
FPE3.DE | FUCHS SE-PREF | N/A | 6.50B | ||
BEWI.OL | BEWI AS | N/A | 4.98B | ||
FPE.DE | FUCHS SE | N/A | 4.85B | ||
SOLV.BR | SOLVAC SA-REG | 10.14 | 2.06B | ||
LEN.DE | LENZING AG | N/A | 1.13B | ||
EXPL.PA | EXPLOSIFS PROD. CHI | 20.95 | 479.12M | ||
HYDRA.AS | HYDRATEC INDUSTRIES NV | 13.63 | 214.50M | ||
SERI.MI | SERI INDUSTRIAL SPA | N/A | 119.57M | ||
ALCRB.PA | CARBIOS | N/A | 99.42M | ||
HOLCO.AS | HOLLAND COLOURS NV | 12.11 | 77.40M | ||
ALAFY.PA | AFYREN SAS | N/A | 43.60M |
Global Bioenergies SA develops industrial processes to convert renewable sources into isobutene. The company is headquartered in Evry, Ile-De-France and currently employs 45 full-time employees. The company went IPO on 2011-06-09. Isobutene, a hydrocarbon, can be converted into fuels such as isooctane, as well as into various materials (synthetic rubber, organic glass, plastics). The process developed by Global Bioenergies SA is based on the design of an artificial metabolic pathway comprising several enzymes catalyzing reactions not observed in nature. Six patent applications have been filed by the Company. The first two applications covering the key steps of the bio-production of isobutene and other olefins have already been published. The company distributes butane and propane containing bio-isobutene, in a e partnership with Global Bioenergies. The company operates through Syngip.
GLOBAL BIOENERGIES SA
5, rue Henri Desbrueres
Evry ILE-DE-FRANCE FR
Employees: 46
Company Website: https://www.global-bioenergies.com/
Investor Relations: http://www.globalbioenergies-invest.com
Phone: 33164982050
The current stock price of ALGBE.PA is 1.248 EUR. The price decreased by -0.16% in the last trading session.
The exchange symbol of GLOBAL BIOENERGIES SA is ALGBE and it is listed on the Euronext Paris - Matif exchange.
ALGBE.PA stock is listed on the Euronext Paris - Matif exchange.
9 analysts have analysed ALGBE.PA and the average price target is 3.37 EUR. This implies a price increase of 169.71% is expected in the next year compared to the current price of 1.248. Check the GLOBAL BIOENERGIES SA stock analysts ratings, price target forecast and up-and down grades for more detailed information.
GLOBAL BIOENERGIES SA (ALGBE.PA) has a market capitalization of 22.68M EUR. This makes ALGBE.PA a Nano Cap stock.
GLOBAL BIOENERGIES SA (ALGBE.PA) currently has 46 employees.
GLOBAL BIOENERGIES SA (ALGBE.PA) has a support level at 1.24 and a resistance level at 1.45. Check the full technical report for a detailed analysis of ALGBE.PA support and resistance levels.
The Revenue of GLOBAL BIOENERGIES SA (ALGBE.PA) is expected to grow by 0.97% in the next year. Check the estimates tab for more information on the ALGBE.PA EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
ALGBE.PA does not pay a dividend.
GLOBAL BIOENERGIES SA (ALGBE.PA) will report earnings on 2025-09-08.
GLOBAL BIOENERGIES SA (ALGBE.PA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.32).
ChartMill assigns a technical rating of 5 / 10 to ALGBE.PA. When comparing the yearly performance of all stocks, ALGBE.PA is one of the better performing stocks in the market, outperforming 79.41% of all stocks.
ChartMill assigns a fundamental rating of 2 / 10 to ALGBE.PA. While ALGBE.PA seems to be doing ok healthwise, there are quite some concerns on its profitability.
Over the last trailing twelve months ALGBE.PA reported a non-GAAP Earnings per Share(EPS) of -0.32. The EPS increased by 32.58% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -53.94% | ||
ROE | -159.25% | ||
Debt/Equity | 1.02 |
ChartMill assigns a Buy % Consensus number of 84% to ALGBE.PA. The Buy consensus is the average rating of analysts ratings from 9 analysts.
For the next year, analysts expect an EPS growth of 21.05% and a revenue growth 0.97% for ALGBE.PA